Workflow
Drug development for chronic cough
icon
Search documents
Trevi Therapeutics(TRVI) - 2024 Q4 - Earnings Call Transcript
2025-03-18 20:30
Trevi Therapeutics Inc (TRVI) Q4 2024 Earnings Call March 18, 2025 04:30 PM ET Company Participants Jennifer Good - Co-Founder, CEO, President & DirectorLisa Delfini - Chief Financial OfficerMayank Mamtani - Senior Managing DirectorAnnabel Samimy - Managing DirectorRyan Deschner - Vice President - Equity ResearchBrandon Folkes - Managing Director - Equity Research Conference Call Participants None - AnalystLeland Gershell - MD & Senior Biotechnology AnalystSerge Belanger - Senior Analyst Operator Good after ...